Condition

ITP - Immune Thrombocytopenia clinical trials and research

• 8Clinical trials
• 15Countries

Newest ITP - Immune Thrombocytopenia clinical trials

All recruiting trials (8)

• Multi-target drugs sequentially combine therapy in adults with newly diagnosed immune thrombocytopenia

  This study tests whether starting with standard steroids plus a TPO-RA, then adding a second targeted therapy if needed, can improve platelet counts in adults with newly diagnosed ITP.

  Recruiting Phase 4 Institute of Hematology & Blood Diseases Hospital, China · Tianjin · NCT07788456

• CTX112 (zugo-cel) for relapsed/refractory ITP and wAIHA in adults

  This trial tests CTX112, an off-the-shelf CD19 CAR-T therapy, to see if it can help adults with relapsed or refractory ITP or wAIHA.

  Recruiting at 12 sites Phase 1/2 CRISPR Therapeutics · Boston, Massachusetts and 11 other locations · NCT07549698

• Efgartigimod IV for adolescents (12–17) with chronic immune thrombocytopenia

  This trial will try intravenous efgartigimod to see if it safely raises platelet counts in people aged 12 to 17 with chronic ITP.

  Recruiting at 26 sites Phase 2/3 argenx · Bordeaux and 25 other locations · NCT07194850

• Lower starting dose of avatrombopag for immune thrombocytopenia (ITP)

  This pilot will try a lower starting dose of avatrombopag to raise platelet counts in adults with primary ITP who need second-line treatment.

  Recruiting Phase 4 Al-Mustansiriyah University · Baghdad · NCT07133659

• Eltrombopag-related liver problems in immune thrombocytopenia

  See if eltrombopag leads to liver dysfunction in adults with immune thrombocytopenia (ITP).

  Recruiting Sohag University · Sohag · NCT07093606

• OM336 for autoimmune hemolytic anemia and immune thrombocytopenia

  This phase 1 trial will test whether subcutaneously given OM336 is safe and tolerable in adults with relapsed or refractory autoimmune hemolytic anemia or immune thrombocytopenia.

  Recruiting at 7 sites Phase 1 Lakefront Biotherapeutics West LLC · Duarte, California and 6 other locations · NCT07083960

• Registry for patients with Primary Immune Thrombocytopenia in Spain

  This study is collecting information from patients with Primary Immune Thrombocytopenia in Spain to better understand the condition and improve how it's treated.

  Recruiting at 29 sites Fundación Española de Hematología y Hemoterapía · A Coruña, A Coruña and 35 other locations · NCT06919341

• CAR-T cell therapy for chronic or refractory immune thrombocytopenia

  This study is testing if CAR-T cell therapy can help people with chronic or hard-to-treat immune thrombocytopenia improve their platelet counts and overall health.

  Recruiting Phase 1/2 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China · Kunming, Yunnan · NCT06352281

Related topics

Quick answers

How many ITP - Immune Thrombocytopenia clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 15 countries. The most sites are in Spain (3 trials), United States (2 trials), China (2 trials), Germany (2 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 2, Phase 1/2: 2, Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →